Dual biologic therapy for patients with Inflammatory Bowel Disease in a single reference center in Spain

被引：0
|
作者：
Lois Palomares, M. T. Diz [1 ]
Porta Sanchez, A. [2 ]
Gonzalez Conde, B. [1 ]
Estevez Prieto, E. [1 ]
Vazquez Rey, M. T. [1 ]
Elberdin Pazos, L. [2 ]
Alonso Aguirre, P. [1 ]
Martin Herranz, I. [2 ]
机构：
[1] A Coruna Univ Hosp, Gastroenterol, La Coruna, Spain
[2] A Coruna Univ Hosp, Pharm Dept, La Coruna, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P740
引用
收藏
页码：870 / 871
页数：2
相关论文
共 50 条
  • [41] LOWER SUSTAINED PERTUSSIS CONCENTRATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGIC THERAPY
    Caldera, Freddy
    McCrone, Sue
    Garmoe, Christine A.
    Megna, Bryant W.
    Ley, Dana
    Reichelderfer, Mark
    Hayney, Mary S.
    GASTROENTEROLOGY, 2017, 152 (05) : S59 - S59
  • [42] Overuse of Tuberculosis Screening Practices in Patients With Inflammatory Bowel Disease on Biologic Therapy
    Vecchio, Eric
    Mao, Eric
    Fine, Sean
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S369 - S369
  • [43] Biologic therapy and the risk of herpes zoster among patients with inflammatory bowel disease
    Santella, Christina
    Bitton, Alain
    Filliter, Christopher
    Vutcovici, Maria
    Bessissow, Talat
    Lakatos, Peter
    Brassard, Paul
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 607 - 607
  • [44] Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease
    Roig, Clara Amiama
    Ferrer, Cristina Suarez
    Garcia, Jose Luis Rueda
    Cordon, Joaquin Poza
    Sanchez-Azofra, Maria
    Arranz, Eduardo Martin
    Diaz, Irene Gonzalez
    Costa, Carmen Amor
    Martin-Arranz, Maria Dolores
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (02): : 109 - 115
  • [45] BIOLOGIC THERAPY PREVENTS COVID RELATED COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Nanah, Rama
    Almasri, Jehad
    Eltelbany, Ahmed
    Nanah, M. Housam
    Khoudari, George
    Nanah, Robana
    Hamid, Osama
    Regueiro, Miguel D.
    GASTROENTEROLOGY, 2023, 164 (06) : S534 - S534
  • [46] Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease
    Abadir, Alexander
    Troia, Angela
    Said, Hyder
    Tarugu, Spurthi
    Billingsley, Benjamin C.
    Sairam, Nathan
    Minchenberg, Scott B.
    Owings, Anna H.
    Parker, Adam M.
    Brousse, Brandon
    Carlyle, Alexander
    Owens, Bobby R.
    Hosseini-Carroll, Pegah
    Galeas-Pena, Michelle
    Frasca, Joseph
    Glover, Sarah C.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (08) : 2796 - 2803
  • [47] ASSOCIATION OF BIOLOGIC THERAPY OVERLAP WITH THE RISK OF INFECTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Kruger, Annie J.
    Dormont, Flavio
    Capit, Nicolas
    Schilsky, Samantha
    Roberts, Andrew
    Lin, Yong
    Badalamenti, Salvatore
    Wiekowski, Maria
    Bewtra, Meenakshi
    Colombel, Jean Frederic
    GASTROENTEROLOGY, 2024, 166 (05) : S1132 - S1133
  • [48] Cytokines and Biologic Therapy in Patients with Inflammatory Bowel Diseases
    Caviglia, Gian Paolo
    Ribaldone, Davide Giuseppe
    Nicolosi, Aurora
    Pellicano, Rinaldo
    GASTROENTEROLOGY INSIGHTS, 2021, 12 (04) : 443 - 445
  • [49] Biologic Therapies, Thiopurines and Cancer in Inflammatory Bowel Disease: A Single-Center Cohort Study Involving 1118 Patients
    Biancone, Livia
    Zuzzi, Sara
    Ranieri, Micaela
    Onali, Sara
    Petruzziello, Carmelina
    Zorzi, Francesca
    Ascolani, Marta
    Lolli, Elisabetta
    Stasi, Elisa
    Sica, Giuseppe S.
    Pallone, Francesco
    GASTROENTEROLOGY, 2010, 138 (05) : S540 - S540
  • [50] Breaking the Therapeutic Ceiling: Dual Biologic or Small Molecule Therapy for Refractory Inflammatory Bowel Disease
    Ahmed, Waseem
    CROHNS & COLITIS 360, 2022, 4 (01)
12345